Stockscreener 앱 받기
33.82
1.14%
0.38
전일 마감가:
$33.44
열려 있는:
$33.51
하루 거래량:
6.85M
Relative Volume:
1.48
시가총액:
$17.27B
수익:
$17.28B
순이익/손실:
$108.00M
주가수익비율:
169.10
EPS:
0.2
순현금흐름:
$391.00M
1주 성능:
+9.73%
1개월 성능:
+7.43%
6개월 성능:
-6.52%
1년 성능:
-19.91%
1일 변동 폭
$33.25
$34.02
1주일 범위
$30.56
$34.02
52주 변동 폭
$28.34
$44.01
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(847) 948-2000
주소
ONE BAXTER PKWY, DEERFIELD, IL
BAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
33.82 | 17.27B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
JPMorgan Chase & Co. Lowers Baxter International (NYSE:BAX) Price Target to $36.00 - MarketBeat
Baxter Q4 2024 revenue up 1% to USD 2.75 billion - Medical Buyer
Medical Device Maker Baxter International's Stock Soars on Strong Earnings - MSN
Baxter International: Resilient Q4 2024 and Strong 2025 Outlook - TipRanks
Baxter International Inc. stock outperforms competitors on strong trading day - MSN
BAXTER INTERNATIONAL INC SEC 10-K Report - TradingView
Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.17 - Simply Wall St
Baxter International (NYSE:BAX) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Baxter International (NYSE:BAX) Shares Gap Up After Strong Earnings - MarketBeat
After tough year, Baxter looks for next CEO to drive growth - MedTech Dive
Baxter International (NYSE:BAX) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Baxter International (NYSE:BAX) Coverage Initiated at Barclays - MarketBeat
Baxter International (NYSE:BAX) Issues FY 2025 Earnings Guidance - MarketBeat
Baxter International (NYSE:BAX) Issues Q1 2025 Earnings Guidance - MarketBeat
Baxter International Inc. (NYSE:BAX) Q4 2024 Earnings Call Transcript - Insider Monkey
Baxter International’s 2025 Outlook: Hold Rating Amid Growth Potential and Leadership Transition - TipRanks
JPMorgan Adjusts Baxter International's Price Target to $36 From $38 -February 21, 2025 at 06:07 am EST - Marketscreener.com
Nicholas Hoffman & Company LLC. Purchases Shares of 31,103 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc (BAX) Q4 2024 Earnings Call Highlights: - GuruFocus.com
Baxter International Inc (BAX) Q4 2024 Earnings Call Highlights: Strong EPS Growth and ... - Yahoo Canada Finance
Baxter International Reports Strong 2024 Financial Performance - TipRanks
ONE strengthening its partnership with Baxter International - Next Investors
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook - AOL
Rhumbline Advisers Grows Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Earnings call transcript: Baxter Q4 2024 earnings beat lifts stock 7% By Investing.com - Investing.com Nigeria
Baxter stock rises on Street-beating, better-than-expected Q4 - Mass Device
Baxter stock surges as earnings beat Wall Street estimates - Crain's Chicago Business
Baxter (BAX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call transcript: Baxter Q4 2024 earnings beat lifts stock 7% - Investing.com
Baxter Exec Says 2025 Forecast Includes A Slight Impact From Tariffs Enacted In ChinaConf Call - Marketscreener.com
Baxter International Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Baxter shares rally as Q4 earnings top estimates - Investing.com
Baxter International Reports Strong Q4 Performance, Surpassing ExpectationsNews and Statistics - IndexBox, Inc.
Baxter International Expects Profits To Exceed Wall Street Hopes - Finimize
Baxter forecasts 2025 profit above estimates on medical device demand; shares rise - MSN
Baxter stock rises after Q4 beat (BAX:NYSE) - Seeking Alpha
Baxter International Inc (BAX) Surpasses Q4 Estimates with $0.58 EPS and $2.75 Billion Revenue - GuruFocus.com
Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars - Yahoo Finance
Baxter shares surge 6% as Q4 earnings top estimates, guidance upbeat - Investing.com Australia
Baxter International's Q4 Adjusted Earnings Fall, Revenue Rises; Q1, 2025 Guidance Issued - Marketscreener.com
Barclays maintains Baxter stock Overweight with $39 target - Investing.com India
Baxter reports Q4 adjusted EPS 58c, consensus 52c - TipRanks
Baxter reinstated with an Overweight at Barclays - TipRanks
SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Baxter Earnings: What To Look For From BAX - The Globe and Mail
International company signs 10-year lease in Reading - Reading Chronicle
Brent Shafer - PharmaTimes
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
Inside Baxter's Growth Strategy: CFO Reveals Future Plans at Major Healthcare Conference - StockTitan
Baxter plant returns to full production after Hurricane Helene disruption - Crain's Chicago Business
Baxter plant damaged by Hurricane Helene returns to regular production levels - Chicago Tribune
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.56%
자본화:
|
볼륨(24시간):